Legalize Psychedelic Medicine

Donate to MAPS' Phase 3 Studies of MDMA-Assisted Psychotherapy for PTSD in Europe

We have nearly completed funding our Phase 3 trials for FDA approval in the U.S. of MDMA-assisted psychotherapy for the treatment of PTSD. However, MAPS still needs approximately $5 million to conduct Phase 3 studies in Europe and seek regulatory approval from the European Medicines Agency (EMA). We aim to make MDMA-assisted psychotheray a legal treatment by 2021 in both the U.S. and Europe.

Donation

If you have a MAPS account, please log in HERE and your contact information will be filled in automatically.

Donation Amount:

This is a one time donation

Make this a recurring donation deducted

I prefer this gift to be anonymous: This gift is in Honor/Memory of: Other Instructions/Comments/Restrictions on Donations:

Your Information

First Name: Last Name: Email: Would you like to receive the MAPS Email Newsletter?

Yes

No, thank you

Phone: Address: Address 2: City: State/Province (US and Canada): State/Province (other): Zip/Postal Code: - Country:

Create Account

If you would like to make a MAPS account, which will enable you to update your address and payment information, view your donation history, and more, please create a login name and password:

Create a Login Name: Login Password: Retype Password:

Neon CRM by Neon One

Legalize Psychedelic Medicine

MAPS

Media

About Us

Contact Us